<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825442</article-id>
    <article-id pub-id-type="pmid">36399488</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac1006</article-id>
    <article-id pub-id-type="publisher-id">gkac1006</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TIMEDB: tumor immune micro-environment cell composition database with automatic analysis and interactive visualization</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8979-3737</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Xueying</given-names>
        </name>
        <aff><institution>Department of Computer Science, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
        <aff><institution>City University of Hong Kong Shenzhen Research Institute</institution>, Guangdong, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5229-7470</contrib-id>
        <name>
          <surname>Chen</surname>
          <given-names>Lingxi</given-names>
        </name>
        <aff><institution>Department of Computer Science, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
        <aff><institution>City University of Hong Kong Shenzhen Research Institute</institution>, Guangdong, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Wei</given-names>
        </name>
        <aff><institution>Department of Computer Science, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yuanzheng</given-names>
        </name>
        <aff><institution>School of Medicine and Biological Information Engineering, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Dawei</given-names>
        </name>
        <aff><institution>School of Software, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Chenxin</given-names>
        </name>
        <aff><institution>School of Business Administration, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shi</surname>
          <given-names>Shuai</given-names>
        </name>
        <aff><institution>School of Creative Media, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dong</surname>
          <given-names>Jiajie</given-names>
        </name>
        <aff><institution>Department of Computer Science, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lai</surname>
          <given-names>Zhengtao</given-names>
        </name>
        <aff><institution>School of Business Administration, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Bingran</given-names>
        </name>
        <aff><institution>School of Business Administration, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Wenjingyu</given-names>
        </name>
        <aff><institution>School of Business Administration, Northeastern University</institution>, Shenyang, Liaoning, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheng</surname>
          <given-names>Haoyue</given-names>
        </name>
        <aff><institution>Department of Clinical Pathology, Capital Medical University</institution>, Beijing, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6246-6349</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Shuaicheng</given-names>
        </name>
        <!--shuaicli@cityu.edu.hk-->
        <aff><institution>Department of Computer Science, City University of Hong Kong</institution>, Hong Kong, <country country="CN">China</country></aff>
        <aff><institution>City University of Hong Kong Shenzhen Research Institute</institution>, Guangdong, <country country="CN">China</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +852 3442 9412; Email: <email>shuaicli@cityu.edu.hk</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first three authors should be considered Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-18">
      <day>18</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D1417</fpage>
    <lpage>D1424</lpage>
    <history>
      <date date-type="accepted">
        <day>21</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>30</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>14</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac1006.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Deciphering the cell-type composition in the tumor immune microenvironment (TIME) can significantly increase the efficacy of cancer treatment and improve the prognosis of cancer. Such a task has benefited from microarrays and RNA sequencing technologies, which have been widely adopted in cancer studies, resulting in extensive expression profiles with clinical phenotypes across multiple cancers. Current state-of-the-art tools can infer cell-type composition from bulk expression profiles, providing the possibility of investigating the inter-heterogeneity and intra-heterogeneity of TIME across cancer types. Much can be gained from these tools in conjunction with a well-curated database of TIME cell-type composition data, accompanied by the corresponding clinical information. However, currently available databases fall short in data volume, multi-platform dataset integration, and tool integration. In this work, we introduce TIMEDB (<ext-link xlink:href="https://timedb.deepomics.org" ext-link-type="uri">https://timedb.deepomics.org</ext-link>), an online database for human tumor immune microenvironment cell-type composition estimated from bulk expression profiles. TIMEDB stores manually curated expression profiles, cell-type composition profiles, and the corresponding clinical information of a total of 39,706 samples from 546 datasets across 43 cancer types. TIMEDB comes readily equipped with online tools for automatic analysis and interactive visualization, and aims to serve the community as a convenient tool for investigating the human tumor microenvironment.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>TIMEDB: tumor immune micro-environment cell composition database with automatic analysis and interactive visualization.</p>
          </caption>
          <graphic xlink:href="gkac1006figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>CityU/UGC Research Matching Grant Scheme</institution>
          </institution-wrap>
        </funding-source>
        <award-id>9229013</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>SIRG</institution>
          </institution-wrap>
        </funding-source>
        <award-id>CityU SIRG 7020005</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>The Science Technology and Innovation Committee of Shenzhen Municipality</institution>
          </institution-wrap>
        </funding-source>
        <award-id>JCYJ20200109143216036</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>In cancer, the tumor immune microenvironment (TIME) is characterized by dynamic interactions between tumor and immune cells (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Deciphering the cell-type composition in the TIME can significantly improve cancer prognosis and increase the efficacy of cancer treatment (<xref rid="B3" ref-type="bibr">3</xref>). TIME cell-type composition could illuminate details on how tumor cells escape the immune response. In clinical trials, TIME cell-type composition can stratify patients and assign the most appropriate treatment regimen according to the target cell types, thus enhancing the treatment options and ultimately improving overall survival (<xref rid="B4" ref-type="bibr">4</xref>).</p>
    <p>Wet-lab approaches like fluorescence-activated cell sorting and immunohistochemical staining have been adopted as the gold standards for assessing the number of immune cells in tumor samples. However, flow cytometry demands plenty of cells, which limits its use in tumor biopsies. Immunohistochemical staining estimates individual tumor dissection slides, which cannot represent the heterogeneous immune panorama of the tumor. Additionally, both methods merely infer a small number of cell types. Recent breakthroughs in single-cell RNA sequencing (scRNA-Seq) have been used to catalog cell type and status. However, it is still costly and tedious for routine clinical applications (<xref rid="B5" ref-type="bibr">5–7</xref>).</p>
    <p>Microarray and bulk RNA sequencing (RNA-Seq) have been widely adopted in cancer studies, accumulating extensive bulk expression profiles with clinical phenotypes in multiple cancers (<xref rid="B6" ref-type="bibr">6</xref>). Present state-of-the-art tools estimate the cell-type composition from bulk expression profiles, allowing the investigation of inter-heterogeneity and intra-heterogeneity of TIME across cancers. However, there are very steep learning curves in running these tools for non-bioinformaticians and in curating the corresponding clinical data for non-clinicians. The task can be made more accessible with a well-curated database that brings together TIME cell-type composition data, the corresponding clinical information, and the tools for effective TIME exploration.</p>
    <p>Existing online databases that estimated TIME cell-type composition from bulk expression profiles include CancerImmunityQTL (<xref rid="B7" ref-type="bibr">7</xref>), GEPIA2021 (<xref rid="B8" ref-type="bibr">8</xref>), TCIA (<xref rid="B9" ref-type="bibr">9</xref>), TISMO (<xref rid="B10" ref-type="bibr">10</xref>), and TIMER2.0 (<xref rid="B11" ref-type="bibr">11</xref>). However, these databases have several limitations. (i) Most of the TIME cell-type composition profiles are estimated from The Cancer Genome Atlas (TCGA) repositories (<xref rid="B12" ref-type="bibr">12</xref>); the TIME cell-type composition profiles from the extensive pool of bulk expression outside TCGA are ineffectively exploited. (ii) The TIME cell-type composition profiles from the state-of-the-art tools are unavailable in the current databases, and the computational biases from different approaches are incompletely presented. (iii) Integration analyses of TIME cell-type composition among multiple datasets are required to infer the landscape of tumor-specific TIME signatures (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). However, such integration analyses from multiple datasets are either missing from these databases or only provided rudimentarily. (iv) These databases offer little in the way of interactive visualizations that are helpful to scientific explorations (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>).</p>
    <p>To overcome these limitations, we propose TIMEDB (<ext-link xlink:href="https://timedb.deepomics.org" ext-link-type="uri">https://timedb.deepomics.org</ext-link>), an online human tumor immune microenvironment cell-type composition database with automatic analysis and interactive visualization. TIMEDB has three key features: (i) A curated TIME database of more than 39,706 samples and 546 datasets across 43 cancers, including bulk expression data, clinical data, TIME cell-type composition data estimated by ten state-of-the-art tools, C1-C6 immune subtyping data, <italic toggle="yes">etc</italic>. (ii) Automatic interfaces of 21 tumor immune microenvironment analyses, including TIME cell-type composition estimation, survival, <italic toggle="yes">etc</italic>. (iii) Interactive visualizations of gene expression, TIME cell-type composition estimation, patient subtyping, survival, and correlation result from the database or analysis.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Data collection</title>
      <p>We first summarized and collected gene expression data for 32 cancer types from Cancer Genome Atlas (TCGA) (<xref rid="B12" ref-type="bibr">12</xref>) and six cancer types from Therapeutically Applicable Research to Generate Effective Treatments (TARGET) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>) (<xref rid="B15" ref-type="bibr">15</xref>) . TCGA clinical data and raw RNA-Seq (HTSeq) counts were downloaded through TCGAbiolinks (<xref rid="B16" ref-type="bibr">16</xref>). Collapsed files from the publicly available TARGET clinical and level 3 gene expression matrix were downloaded from <ext-link xlink:href="https://ocg.cancer.gov/programs/target/data-matrix" ext-link-type="uri">https://ocg.cancer.gov/programs/target/data-matrix</ext-link> (<xref rid="B15" ref-type="bibr">15</xref>). Then, we conducted a systematic search in Gene Expression Omnibus (GEO, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geoprofiles/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geoprofiles/</ext-link>) (<xref rid="B17" ref-type="bibr">17</xref>) and the Array Express portal (<ext-link xlink:href="https://www.ebi.ac.uk/arrayexpress/" ext-link-type="uri">https://www.ebi.ac.uk/arrayexpress/</ext-link>) (<xref rid="B18" ref-type="bibr">18</xref>) with the names of 38 cancer types and ‘Expression Profile’ as keywords during June 2021–June 2022. As a result, we collected a total of 39,706 samples from 546 publicly available datasets with curated clinical information and gene expression profiles. The brief descriptions and references of the 546 datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Clinical data curation</title>
      <p>We manually assigned each sample to 38 cancer types according to their primary lesions and metastatic statuses. Tumors other than the 38 types were assigned to SCLC (Small Cell Lung Cancer), CLL (Chronic Lymphocytic Leukemia), RT (Rhabdoid Tumor), CML (Chronic Myelogenic Leukemia), and Other, resulting a total of 43 cancer types except ‘Other’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). We curated two primary endpoints for each dataset: overall survival (OS) and progression-free survival (PFS). OS refers to the date of diagnosis to death or the last follow-up, and PFS indicates the date of recurrence/relapse/progression or last follow-up. Tumor subtype, stage, grade, type, metastasis, treatment response, <italic toggle="yes">etc</italic>., are curated if available. All manually curated profiles are checked by at least three individuals. The curation details can be viewed at the ‘Curated Clinical Headers’ on each dataset information page. Here, we also included any available normal or blood samples labeled with ‘tumor_subtype: normal’ in each dataset.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Bulk expression profiles preprocessing</title>
      <p>We first transferred the array probe id (microarray) or the gene ensemble id (RNA-Seq) to the HUGO gene symbol for each data set. Duplicated gene entries are aggregated with their mean expression data. The normalization and transformation of the expression data conform to the guiding principles of Quackenbush (<xref rid="B19" ref-type="bibr">19</xref>), Ali <italic toggle="yes">et al.</italic> (<xref rid="B1" ref-type="bibr">1</xref>), and Gao <italic toggle="yes">et al.</italic> (<xref rid="B2" ref-type="bibr">2</xref>). We applied quantile normalization, log<sub>2</sub>, and scale to microarray intensity datasets. We converted the raw count of RNA-Seq into logarithmic transcripts per kilobase million (log<sub>2</sub> TPM) values. The preprocessing steps for each dataset are recorded in the ‘Dataset’ table with the ‘TIMEDB_RNA_process’ field.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Batch effect elimination</title>
      <p>In an analysis involving multiple datasets, we employed sva (<xref rid="B20" ref-type="bibr">20</xref>) to eliminate batch effects of expression profiles from different datasets or platforms. We applied Uniform Manifold Approximation and Projection (UMAP) (<xref rid="B21" ref-type="bibr">21</xref>) into the expression profiles to check the efficacy of the batch effect elimination. In the UMAP plot (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1A</xref>), each point represents a sample. Before batch effect removal, samples in different datasets and platforms stay apart in the UMAP plot. After batch-effect removal, samples with the same molecular characteristics from different datasets or platforms tend to be mixed (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1B</xref>).</p>
    </sec>
    <sec id="SEC2-5">
      <title>TIME cell-type composition quality control, estimation, and other data processing</title>
      <p>The details of the TIME cell-type composition quality control, estimation, and further data processing are recorded in Supplementary Methods.</p>
    </sec>
    <sec id="SEC2-6">
      <title>Platform development</title>
      <p>TIMEDB is hosted on a CentOS 7.4 server with 128GB memory and 60TB storage. The backend is supported by in-house framework (<xref rid="B22" ref-type="bibr">22</xref>), consisting of Ruby (v2.7.1), Ruby on Rails (v6.0.2), Apache (v2.4.6), and PostgreSQL (v12.3). The frontend support includes HTML5, Bootstrap4, ES6, Node.js, Vue.js (v2.6.10), and Oviz (<xref rid="B13" ref-type="bibr">13</xref>) (<ext-link xlink:href="https://oviz.org" ext-link-type="uri">https://oviz.org</ext-link>). We have tested TIMEDB on the following operating systems and browsers. Linux: Firefox, Chrome; macOS: Chrome, Firefox, Safari, Edge; Windows: Firefox, Edge, and Chrome.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <sec id="SEC3-1">
      <title>TIMEDB database</title>
      <p>TIMEDB holds curated gene expression profiles and the corresponding clinical information (basic characteristics, survival, <italic toggle="yes">etc</italic>.) from a total of 39,706 samples across 546 datasets across 43 cancer types (Figure <xref rid="F1" ref-type="fig">1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>, and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S2–S3</xref>). Sequencing protocols include microarray and RNA-Seq. The data sources consist of TCGA, TARGET, GEO (<xref rid="B17" ref-type="bibr">17</xref>), and ArrayExpress (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>The overview of TIMEDB database design.</p>
        </caption>
        <graphic xlink:href="gkac1006fig1" position="float"/>
      </fig>
      <p>TIMEDB stores the TIME cell-type composition profiles estimated by ten state-of-the-art methods. TIME cell-type composition estimation methods are classified into regression-based deconvolution approaches and gene set enrichment-based approaches. ABIS performs deconvolution of the absolute cell proportion of 29 immune cell types on RNA-Seq and microarray data (<xref rid="B23" ref-type="bibr">23</xref>). CIBERSORT infers the fraction of 22 TIME cell types from gene expression data (<xref rid="B24" ref-type="bibr">24</xref>). This method relies on cell-specific gene signatures and Nu-support vector regression. CIBERSORTx, which extends on CIBERSORT, incorporates ComBat to address possible cross-platform batch effects in gene experssion data (<xref rid="B25" ref-type="bibr">25</xref>). EPIC quantitatively analyzes the ratio of immune and non-tumor cells in TIME from expression profiles by applying constrained least squares regression (<xref rid="B26" ref-type="bibr">26</xref>). The quanTIseq method quantifies the proportion of ten different immune cell types and the proportion of other noncharacteristic cells from bulk gene expression of heterogeneous samples. It solves cell-type composition devolution problems by constrained least squares regression (<xref rid="B27" ref-type="bibr">27</xref>). TIMER selects marker genes negatively correlated with tumor purity for 32 cancer types from TCGA. It adopts constrained least squares to infer the fraction of six immune cell types (<xref rid="B28" ref-type="bibr">28</xref>). TIMEDB database stores the predicted cell-type composition profiles of ABIS, CIBERSORT, CIBERSORTx, EPIC, quanTIseq, and TIMER of the datasets 513, 513, 507, 37, 512, and 455, respectively.</p>
      <p>In addition, there are four enrichment-based tools. ConsensusTME (<xref rid="B29" ref-type="bibr">29</xref>) is an ssGSEA-based approach. It first integrates gene sets from Bindea <italic toggle="yes">et al.</italic> (<xref rid="B30" ref-type="bibr">30</xref>), Davoli <italic toggle="yes">et al.</italic> (<xref rid="B31" ref-type="bibr">31</xref>), Danaher <italic toggle="yes">et al.</italic> (<xref rid="B32" ref-type="bibr">32</xref>), CIBERSORT LM22 (<xref rid="B24" ref-type="bibr">24</xref>), MCPcounter (<xref rid="B33" ref-type="bibr">33</xref>), TIMER (<xref rid="B28" ref-type="bibr">28</xref>), and xCell (<xref rid="B34" ref-type="bibr">34</xref>). Then, consensus marker genes for 18 cell types and 32 TCGA cancer types are curated. This package allows users to choose a type of TCGA cancer and uses ssGSEA to generate normalized enrichment scores and infer the relative TIME cell-type fractions. ImmuCellAI is an online cell abundance identifier based on ssGSEA, explicitly focusing on determining the abundance of 18 T cell subtypes (<xref rid="B35" ref-type="bibr">35</xref>). MCPcounter quantifies the absolute abundance of eight immune cell types and two stromal cell types from gene expression data via ssGSEA (<xref rid="B33" ref-type="bibr">33</xref>). xCell is a cell quantitative analysis tool based on ssGSEA; it calculates the enrichment fraction of 64 types of immune and nonimmune cells (<xref rid="B34" ref-type="bibr">34</xref>). In the TIMEDB database, we obtained ConsensusTME-, ImmuCellAI-, MCPcounter-, and xCell-inferred cell abundance for the 452, 475, 483, and 461 datasets, respectively.</p>
      <p>Furthermore, TIMEDB provides the consensus and integrated TIME cell-type composition estimation by ten state-of-the-art tools for each dataset. The consensus result removes cell types that occur only once among ten tools. The integration result means that the cell-type composition is inferred from all tools, and the composition profiles of all cell types are combined into one file.</p>
      <p>TIMEDB also keeps <italic toggle="yes">immune subtypes</italic> predicted by ImmuneSubtypeClassifier (<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>), which forms a part of the ‘Immune Landscape of Cancer’ (<xref rid="B38" ref-type="bibr">38</xref>). The tool accepts RNA sequencing data as input and calculates the probabilities for a patient concerning six immune statuses, including C1 (wound healing), C2 (IFN-γ dominant), C3 (inflammatory), C4 (lymphocyte depleted), C5 (immunologically quiet), and C6 (TGF-β dominant). Currently, TIMEDB contains the ImmuneSubtypeClassifier-inferred C1–C6 subtyping results for 511 curated datasets.</p>
      <p>The ‘Immune Landscape of Cancer’ (<xref rid="B38" ref-type="bibr">38</xref>) also asserts seventy-nine immunomodulators. These immunomodulating proteins can be categorized into TNF, MHC Class II, Immunoglobulin, or CXC chemokine gene family; they can also be classified into ligand, receptor, or antigen presentation. From an immune checkpoint view, they can be inhibitory or stimulatory. In the TIMEDB database, we provide 520 immunomodulatory gene expression profiles from curated datasets.</p>
    </sec>
    <sec id="SEC3-2">
      <title>TIMEDB analysis</title>
      <p>TIMEDB offers an automatic TIME analysis workflow for researchers to run their newly sequenced bulk expression profiles (Figure <xref rid="F2" ref-type="fig">2</xref>). This workflow includes all the tools mentioned earlier for TIME cell-type composition estimation, TIME cell-type composition-guided patient subtyping, survival analysis, correlation analysis, differential expression analysis, <italic toggle="yes">etc</italic>. Users can upload their gene expression data or select TIMEDB datasets for independent or integrated analyzes with simple mouse operations.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>The overview of TIMEDB analysis design.</p>
        </caption>
        <graphic xlink:href="gkac1006fig2" position="float"/>
      </fig>
      <p>Regarding TIME estimation, with the exception of CIBERSORTx and ImmunecellAI, which only provide online interfaces, all remaining composition estimation tools are included in the TIMEDB analysis interfaces. We have five deconvolution-based interfaces: ‘TIMEDB Deconv ABIS’, ‘TIMEDB Deconv CIBERSORT’, ‘TIMEDB Deconv EPIC’, ‘TIMEDB Deconv quanTIseq’, and ‘TIMEDB Deconv TIMER’. Similarly, we have three enrichment-based analysis interfaces: ‘TIMEDB Deconv ConsensusTME’, ‘TIMEDB Deconv MCPcounter’, and ‘TIMEDB Deconv xCell’. TIMEDB also includes the LinSeed software into the analysis interface ‘TIMEDB Deconv LinSeed’. Unlike supervised prediction, Linseed utilizes nonnegative matrix factorization to reveal the TIME cell-type composition without prior knowledge of the cell types and their abundances (<xref rid="B39" ref-type="bibr">39</xref>). It predicts the fraction of <italic toggle="yes">k</italic> TIME cell subtypes and the gene signatures of the corresponding cell subtypes. Users need to manually annotate resolved cell subtypes.RNA-Seq</p>
      <p>Furthermore, TIMEDB implements ‘TIME Consensus RNA-Seq’, ‘TIME Consensus Array’, ‘TIMEDB ALL RNA-Seq’, and ‘TIMEDB ALL Array’ to provide comparison analysis among different datasets and estimation tools. ‘Consensus’ mode keeps cell types occurring more than twice among different tools, and the ‘All’ mode combines absolute results for all TIME cell types.</p>
      <p>TIMEDB also supports several downstream immune analyses. Molecular subtyping of tumors is an approach to categorizing cancer patients into different subgroups based on molecular profiles and unsupervised clustering tools. ImmuneSubtypeClassifier is included in TIMEDB as the analysis interface ‘TIMEDB C1–C6 Subtyping’ for researchers to predict the six immune statuses, C1–C6 as explained in database section. Moreover, we provide the TIME cell-type composition-guided patient subtyping. Unsupervised clustering approaches, including <italic toggle="yes">k</italic>-means, hierarchical clustering, and nonnegative matrix factorization, are available in the analysis interface ‘TIMEDB Cell Fraction Subtyping’. Furthermore, we group the patients into quantiles based on the TIME cell-type composition and consider the quantiles as the patient subtype. For example, patients can be classified into Q1 B cell (0–25%), Q2 B cell (25–50%), Q3 B cell (50–75%), and Q4 B cell (75–100%) according to the quantiles of the fraction of B cell types.</p>
      <p>Survival analysis is essential to draw the clinical implication from TIME cell-type composition. The Kaplan–Meier (KM) study shows the probability of OS or PFS for a patient subgroup at a specific time, illustrating the difference in prognostic events between different subtypes of patients. The hazard ratio (HR) and the odds ratio (OR) of prognostic associations between the subtypes of patients and survival outcomes customized (OS or PFS) are also vital prognostic indications. Here, the ‘TIMEDB KM Estimator’ and ‘TIMEDB HR OR’ allow researchers to run their newly sequenced data and custom clinical subgroup labels.</p>
      <p>Cell-type interaction and correlation are essential in TIME. We provide ‘TIMEDB Correlation’ and ‘TIMEDB Interaction’ for researchers to calculate the Pearson correlation and associated significance test.</p>
      <p>Understanding the expressions of immunomodulatory genes in different stages of TIME is critical for immunotherapy (<xref rid="B38" ref-type="bibr">38</xref>). TIMEDB provides an analysis interface ‘TIMEDB Immunoregulator’ that shows the differential expression of immunomodulatory genes among different patient subtypes, including tumor grades, tumor stages, tumor types, <italic toggle="yes">etc</italic>., wherever available.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Interactive visualization</title>
      <p>TIMEDB supports interactive visualizations of TIME cell-type composition estimation (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S4 and S5</xref>), patient subtyping (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6 and S7</xref>), survival (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8–S10</xref>), cell-type correlation, interaction (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S11 and S12</xref>), and immunoregulator data (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S13</xref>) from databases or analyses (Figure <xref rid="F3" ref-type="fig">3</xref>). Multiple interaction options are available, including informative tooltips, changeable plot size, edited labels, and color picker, <italic toggle="yes">etc</italic>. All visualizations are downloadable in high-quality publication-ready format.</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>The overview of TIMEDB visualization design.</p>
        </caption>
        <graphic xlink:href="gkac1006fig3" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>DISCUSSION</title>
    <p>Understanding the cell-type composition in the tumor immune microenvironment (TIME) can significantly improve the cancer prognosis and increase cancer treatment efficacy. Here, we present TIMEDB, an online human tumor immune microenvironment cell-type composition database with automatic analysis and interactive visualization. TIMEDB has the following merits compared to existing online TIME cell-type composition databases and webservers (Table <xref rid="tbl1" ref-type="table">1</xref>):</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>Comparison of existing TIME databases and webservers. ‘<inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math></inline-formula>’ for available and ‘-’ for not applicable. ‘x’ signifies offered but unworkable. For instance, CancerImmunityQTL offered downloadable datasets, but no dataset could be downloaded when the button was clicked. In addition, CancerImmunityQTL provides some visualizations about the cell-type composition and KM survival estimation, but the current version does not successfully display these visualizations. ‘o’ means only a few are included. For example, TCIA merely collects one GEO dataset GSE78220. KM: Kaplan Meier.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1"/>
            <th colspan="3" align="center" rowspan="1">Human TIME database</th>
            <th colspan="2" align="center" rowspan="1">Human TIME analysis webserver</th>
            <th rowspan="1" colspan="1">Mouse TIME database</th>
          </tr>
          <tr>
            <th colspan="3" rowspan="1">Functionality</th>
            <th rowspan="1" colspan="1">TIMEDB (2022)</th>
            <th rowspan="1" colspan="1">CancerImmunityQTL (2021)</th>
            <th rowspan="1" colspan="1">TCIA (2016)</th>
            <th rowspan="1" colspan="1">GEPIA (2021)</th>
            <th rowspan="1" colspan="1">TIMER2.0 (2020)</th>
            <th rowspan="1" colspan="1">TISMO (2022)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Database</td>
            <td rowspan="1" colspan="1">Data source</td>
            <td rowspan="1" colspan="1">TCGA</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TARGET</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">ArrayExpress</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">GEO</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">◯</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TIME</td>
            <td rowspan="1" colspan="1">Bulk expression profiles</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">x</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">basic</td>
            <td rowspan="1" colspan="1">Curated clinical profiles</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TIME</td>
            <td rowspan="1" colspan="1">ABIS</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">cell-type</td>
            <td rowspan="1" colspan="1">CIBERSORT</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">x</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">composition</td>
            <td rowspan="1" colspan="1">CIBERSORTx</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">ConsensusTME</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">EPIC</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">ImmucellAI</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MCPcounter</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">quanTIseq</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TIMER</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">xCell</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Consensus</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">ALL</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TIME</td>
            <td rowspan="1" colspan="1">Patients subtyping</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">x</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">advanced</td>
            <td rowspan="1" colspan="1">Survival</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">x</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Immunoregulator</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Total</td>
            <td rowspan="1" colspan="1">Cancer types</td>
            <td rowspan="1" colspan="1">43</td>
            <td rowspan="1" colspan="1">33</td>
            <td rowspan="1" colspan="1">20</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">number</td>
            <td rowspan="1" colspan="1">Datasets number</td>
            <td rowspan="1" colspan="1">546</td>
            <td rowspan="1" colspan="1">33</td>
            <td rowspan="1" colspan="1">24</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Sample number</td>
            <td rowspan="1" colspan="1">39706</td>
            <td rowspan="1" colspan="1">8514</td>
            <td rowspan="1" colspan="1">9672</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Analysis</td>
            <td rowspan="1" colspan="1">TIME</td>
            <td rowspan="1" colspan="1">ABIS</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">cell-type</td>
            <td rowspan="1" colspan="1">CIBERSORT</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00033" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00034" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00035" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">composition</td>
            <td rowspan="1" colspan="1">ConsensusTME</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00036" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00037" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00038" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00039" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">EPIC</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00040" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Linseed</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00041" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MCPcounter</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00042" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00043" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00044" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00045" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">quanTIseq</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00046" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00047" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00048" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TIMER</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00049" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00050" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00051" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">xCell</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00052" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00053" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00054" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Consensus</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00055" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00056" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00057" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">ALL</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00058" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00059" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00060" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Multiple datasets</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00061" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00062" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00063" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Others</td>
            <td rowspan="1" colspan="1">Patients subtyping</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00064" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">KM estimation</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00065" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00066" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Hazard ratio</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00067" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Odds ratio</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00068" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Cell correlation</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00069" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00070" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Cell interaction</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00071" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Immunoregulator</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00072" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Visualization</td>
            <td rowspan="1" colspan="1">Interactive</td>
            <td rowspan="1" colspan="1">Informative tooltips</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00073" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00074" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00075" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00076" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Changeable plot size</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00077" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Editable label</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00078" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Color picker</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00079" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
            <td rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Downloadable</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00080" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">x</td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00081" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00082" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00083" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
            <td rowspan="1" colspan="1">
              <inline-formula>
                <tex-math id="M00084" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\checkmark$\end{document}</tex-math>
              </inline-formula>
            </td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>First, TIMEDB manually curated bulk expression and clinical profiles of 39,678 samples and 545 datasets across 43 types of cancer from TCGA, TARGET, GEO, and Array Express. Other databases such as CancerImmunityQTL, GEPIA2021, TCIA and TIMER2.0 only contain 33, 33, 33 and 32 TCGA datasets, respectively. TIMEDB provides the opportunity to effectively explore the heterogeneity of TIME from the extensive pool of bulk expression profiles outside TCGA.</p>
    <p>Second, we conducted TIME cell estimation using ten state-of-the-art tools, including ABIS, CIBERSORT, CIBERSORTx, EPIC, quanTIseq, TIMER, ConsensusTME, ImmuneCellAI, MCPcounter, and xCell. Such comprehensive TIME cell-type composition profiles from state-of-the-art tools are unavailable in existing databases. For instance, CancerImmunityQTL, GEPIA2021, TCIA, and TIMER2.0 only adopted one (CIBERSORT), one (CIBERSORT), and three (CIBERSORT, EPIC, quanTIseq), and six (CIBERSORT, EPIC, quanTIseq, TIMER, MCPcounter, xCell) estimation tools, respectively. This comprehensiveness can help avoid possible computational biases in the individual tool. Third, TIMEDB infers the landscape of tumor-specific TIME signatures through integration analysis of TIME cell-type composition among multiple datasets, including the above TIME cell-type composition estimation tools, TIME cell-type composition guided patient subtyping, survival analysis, correlation analysis, differential expression analysis, <italic toggle="yes">etc</italic>. In contrast, CancerImmunityQTL and TCIA databases do not support online analysis. GEPIA2021, TISMO, and TIMER2.0 embed a few TIME cell-type composition tools and do not have inconvenient integration analyses for multiple datasets.</p>
    <p>Fourth, TIMEDB provides informative visualizations to boost productive scientific explorations, including gene expression, TIME cell-type composition, patient subtyping, survival, and correlation data from databases or analyses. Multiple interaction options are available, including informative tooltips, changeable plot size, edited labels, optional color picker, <italic toggle="yes">etc</italic>. All visualizations are available for download in a high-quality publication-ready format. In contrast, CancerImmunityQTL, TISMO, and TIMER2.0 only provide static low-resolution pictures.</p>
    <p>One thing to note here is that TIMEDB focuses on the cell-type composition profiles estimated from the bulk expression. Recent breakthroughs in scRNA-Seq have been used to classify cell types and states in TIME with single-cell resolution. Currently, we are collecting and collating cell-type composition profiles from scRNA-Seq for the upgraded version of TIMEDB.</p>
    <p>With comprehensive TIME cell-type composition profiles, analyses, and visualizations at the pan-cancer level, we envision TIMEDB to become a convenient tool for scientists to investigate the biological understanding of human tumor microenvironment study.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>All the data and visualizations described are freely available at <ext-link xlink:href="https://timedb.deepomics.org" ext-link-type="uri">https://timedb.deepomics.org</ext-link>. Users can report any issues in <ext-link xlink:href="https://github.com/deepomicslab/TIMEDB" ext-link-type="uri">https://github.com/deepomicslab/TIMEDB</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac1006_Supplemental_Files</label>
      <media xlink:href="gkac1006_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank Mr. Bowen Tan, Miss. Yanfei Wang, Miss. Lijia Che, and Mr. Shuo Yang for providing backend technical support. The authors thank Dr. Yinan Wang and Miss. Mengyao Wang for valuable suggestions. The authors thank Mr. Changzheng Wang and Miss. Jing Li for the discussion. We would like to sincerely thank Dr. Yen Kaow Ng for language refinement.</p>
    <p><italic toggle="yes">Author contributions:</italic> S.C.L. supervised the project. X.Y.W. and L.X.C. designed the study and implemented the analysis. W.L., Y.Z.Z., D.W.L., and J.J.D. developed the platform. X.Y.W., L.X.C., Y.Z.Z., C.X.Z., Z.T.L., W.L., B.R.Z., W.J.Y.Z., and H.Y.C. collected and curated datasets. S.S. designed the webpage user interface. L.X.C. and X.Y.W. wrote the manuscript. S.C.L. revised the manuscript. All authors read and approved the final manuscript.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac1006#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>CityU/UGC Research Matching Grant Scheme [9229013] and SIRG [CityU SIRG 7020005] Funding for open access charge: CityU/UGC Research Matching Grant Scheme [9229013] and The Science Technology and Innovation Committee of Shenzhen Municipality (Project No. JCYJ20200109143216036).</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali</surname><given-names>H.R.</given-names></string-name>, <string-name><surname>Chlon</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pharoah</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Markowetz</surname><given-names>F.</given-names></string-name>, <string-name><surname>Caldas</surname><given-names>C.</given-names></string-name></person-group><article-title>Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study</article-title>. <source>PLoS Med.</source><year>2016</year>; <volume>13</volume>:<fpage>e1002194</fpage>.<pub-id pub-id-type="pmid">27959923</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>G.</given-names></string-name>, <string-name><surname>Xiong</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Q.</given-names></string-name></person-group><article-title>Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study</article-title>. <source>Oncoimmunology</source>. <year>2020</year>; <volume>9</volume>:<fpage>1760067</fpage>.<pub-id pub-id-type="pmid">32391193</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galli</surname><given-names>F.</given-names></string-name>, <string-name><surname>Aguilera</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Palermo</surname><given-names>B.</given-names></string-name>, <string-name><surname>Markovic</surname><given-names>S.N.</given-names></string-name>, <string-name><surname>Nisticò</surname><given-names>P.</given-names></string-name>, <string-name><surname>Signore</surname><given-names>A.</given-names></string-name></person-group><article-title>Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy</article-title>. <source>J. Exp. Clin. Cancer Res.</source><year>2020</year>; <volume>39</volume>:<fpage>89</fpage>.<pub-id pub-id-type="pmid">32423420</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quezada</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Peggs</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Simpson</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Allison</surname><given-names>J.P.</given-names></string-name></person-group><article-title>Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication</article-title>. <source>Immunol. Rev.</source><year>2011</year>; <volume>241</volume>:<fpage>104</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">21488893</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galluzzi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Senovilla</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zitvogel</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kroemer</surname><given-names>G.</given-names></string-name></person-group><article-title>The secret ally: immunostimulation by anticancer drugs</article-title>. <source>Nat. Rev. Drug Disc.</source><year>2012</year>; <volume>11</volume>:<fpage>215</fpage>–<lpage>33</lpage>.</mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sturm</surname><given-names>G.</given-names></string-name>, <string-name><surname>Finotello</surname><given-names>F.</given-names></string-name>, <string-name><surname>Petitprez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Baumbach</surname><given-names>J.</given-names></string-name>, <string-name><surname>Fridman</surname><given-names>W.H.</given-names></string-name>, <string-name><surname>List</surname><given-names>M.</given-names></string-name>, <string-name><surname>Aneichyk</surname><given-names>T.</given-names></string-name></person-group><article-title>Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology</article-title>. <source>Bioinformatics</source>. <year>2019</year>; <volume>35</volume>:<fpage>i436</fpage>–<lpage>i445</lpage>.<pub-id pub-id-type="pmid">31510660</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ru</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>C.N.</given-names></string-name>, <string-name><surname>Tong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>S.S.W.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>W.C.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>K.C.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Lau</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TISIDB: an integrated repository portal for tumor–immune system interactions</article-title>. <source>Bioinformatics</source>. <year>2019</year>; <volume>35</volume>:<fpage>4200</fpage>–<lpage>4202</lpage>.<pub-id pub-id-type="pmid">30903160</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>F.</given-names></string-name></person-group><article-title>GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W242</fpage>–<lpage>W246</lpage>.<pub-id pub-id-type="pmid">34050758</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Charoentong</surname><given-names>P.</given-names></string-name>, <string-name><surname>Finotello</surname><given-names>F.</given-names></string-name>, <string-name><surname>Angelova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mayer</surname><given-names>C.</given-names></string-name>, <string-name><surname>Efremova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rieder</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hackl</surname><given-names>H.</given-names></string-name>, <string-name><surname>Trajanoski</surname><given-names>Z.</given-names></string-name></person-group><article-title>Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade</article-title>. <source>Cell Rep.</source><year>2017</year>; <volume>18</volume>:<fpage>248</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">28052254</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ouardaoui</surname><given-names>N.</given-names></string-name>, <string-name><surname>Li</surname><given-names>D.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D1391</fpage>–<lpage>D1397</lpage>.<pub-id pub-id-type="pmid">34534350</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Fu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.S.</given-names></string-name></person-group><article-title>TIMER2. 0 for analysis of tumor-infiltrating immune cells</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>W509</fpage>–<lpage>W514</lpage>.<pub-id pub-id-type="pmid">32442275</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab></person-group><article-title>Integrated genomic analyses of ovarian carcinoma</article-title>. <source>Nature</source>. <year>2011</year>; <volume>474</volume>:<fpage>609</fpage>–<lpage>615</lpage>.<pub-id pub-id-type="pmid">21720365</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>W.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.C.</given-names></string-name></person-group><article-title>Oviz-Bio: a web-based platform for interactive cancer genomics data visualization</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>W415</fpage>–<lpage>W426</lpage>.<pub-id pub-id-type="pmid">32392343</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Qing</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.C.</given-names></string-name></person-group><article-title>Somatic variant analysis suite: copy number variation clonal visualization online platform for large-scale single-cell genomics</article-title>. <source>Brief. Bioinform.</source><year>2022</year>; <volume>23</volume>:<fpage>bbab452</fpage>.<pub-id pub-id-type="pmid">34671807</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farrar</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Schuback</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Ries</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Wai</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hampton</surname><given-names>O.A.</given-names></string-name>, <string-name><surname>Trevino</surname><given-names>L.R.</given-names></string-name>, <string-name><surname>Alonzo</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Guidry Auvil</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Davidsen</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Gesuwan</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse</article-title>. <source>Cancer Res.</source><year>2016</year>; <volume>76</volume>:<fpage>2197</fpage>–<lpage>2205</lpage>.<pub-id pub-id-type="pmid">26941285</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Colaprico</surname><given-names>A.</given-names></string-name>, <string-name><surname>Silva</surname><given-names>T.C.</given-names></string-name>, <string-name><surname>Olsen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garofano</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cava</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garolini</surname><given-names>D.</given-names></string-name>, <string-name><surname>Sabedot</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Malta</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Pagnotta</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Castiglioni</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>e71</fpage>.<pub-id pub-id-type="pmid">26704973</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edgar</surname><given-names>R.</given-names></string-name>, <string-name><surname>Domrachev</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lash</surname><given-names>A.E.</given-names></string-name></person-group><article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res.</source><year>2002</year>; <volume>30</volume>:<fpage>207</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="pmid">11752295</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parkinson</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kapushesky</surname><given-names>M.</given-names></string-name>, <string-name><surname>Shojatalab</surname><given-names>M.</given-names></string-name>, <string-name><surname>Abeygunawardena</surname><given-names>N.</given-names></string-name>, <string-name><surname>Coulson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Farne</surname><given-names>A.</given-names></string-name>, <string-name><surname>Holloway</surname><given-names>E.</given-names></string-name>, <string-name><surname>Kolesnykov</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lilja</surname><given-names>P.</given-names></string-name>, <string-name><surname>Lukk</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ArrayExpress--a public database of microarray experiments and gene expression profiles</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D747</fpage>–<lpage>D750</lpage>.<pub-id pub-id-type="pmid">17132828</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quackenbush</surname><given-names>J.</given-names></string-name></person-group><article-title>Microarray data normalization and transformation</article-title>. <source>Nat. Genetics</source>. <year>2002</year>; <volume>32</volume>:<fpage>496</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">12454644</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>W.E.</given-names></string-name>, <string-name><surname>Parker</surname><given-names>H.S.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Storey</surname><given-names>J.D.</given-names></string-name></person-group><article-title>The sva package for removing batch effects and other unwanted variation in high-throughput experiments</article-title>. <source>Bioinformatics</source>. <year>2012</year>; <volume>28</volume>:<fpage>882</fpage>–<lpage>883</lpage>.<pub-id pub-id-type="pmid">22257669</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Becht</surname><given-names>E.</given-names></string-name>, <string-name><surname>McInnes</surname><given-names>L.</given-names></string-name>, <string-name><surname>Healy</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dutertre</surname><given-names>C.-A.</given-names></string-name>, <string-name><surname>Kwok</surname><given-names>I.W.</given-names></string-name>, <string-name><surname>Ng</surname><given-names>L.G.</given-names></string-name>, <string-name><surname>Ginhoux</surname><given-names>F.</given-names></string-name>, <string-name><surname>Newell</surname><given-names>E.W.</given-names></string-name></person-group><article-title>Dimensionality reduction for visualizing single-cell data using UMAP</article-title>. <source>Nat. Biotech.</source><year>2019</year>; <volume>37</volume>:<fpage>38</fpage>–<lpage>44</lpage>.</mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Che</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.C.</given-names></string-name></person-group><article-title>GutMeta: online microbiome analysis and interactive visualization with build-in curated human gut microbiome database</article-title>. <year>2022</year>; <comment>bioRxiv doi:</comment><comment>27 September 2022, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/2022.09.26.509484</pub-id>.</mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Monaco</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>B.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Mustafah</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hwang</surname><given-names>Y.Y.</given-names></string-name>, <string-name><surname>Carré</surname><given-names>C.</given-names></string-name>, <string-name><surname>Burdin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Visan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ceccarelli</surname><given-names>M.</given-names></string-name>, <string-name><surname>Poidinger</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types</article-title>. <source>Cell Rep.</source><year>2019</year>; <volume>26</volume>:<fpage>1627</fpage>–<lpage>1640</lpage>.<pub-id pub-id-type="pmid">30726743</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Newman</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Green</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Gentles</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hoang</surname><given-names>C.D.</given-names></string-name>, <string-name><surname>Diehn</surname><given-names>M.</given-names></string-name>, <string-name><surname>Alizadeh</surname><given-names>A.A.</given-names></string-name></person-group><article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>. <source>Nat. Methods</source>. <year>2015</year>; <volume>12</volume>:<fpage>453</fpage>–<lpage>457</lpage>.<pub-id pub-id-type="pmid">25822800</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Newman</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Steen</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Gentles</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Chaudhuri</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Scherer</surname><given-names>F.</given-names></string-name>, <string-name><surname>Khodadoust</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Esfahani</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Luca</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Steiner</surname><given-names>D.</given-names></string-name></person-group><article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry</article-title>. <source>Nat. Biotech.</source><year>2019</year>; <volume>37</volume>:<fpage>773</fpage>.</mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Racle</surname><given-names>J.</given-names></string-name>, <string-name><surname>de Jonge</surname><given-names>K.</given-names></string-name>, <string-name><surname>Baumgaertner</surname><given-names>P.</given-names></string-name>, <string-name><surname>Speiser</surname><given-names>D.E.</given-names></string-name>, <string-name><surname>Gfeller</surname><given-names>D.</given-names></string-name></person-group><article-title>Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data</article-title>. <source>elife</source>. <year>2017</year>; <volume>6</volume>:<fpage>e26476</fpage>.<pub-id pub-id-type="pmid">29130882</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Finotello</surname><given-names>F.</given-names></string-name>, <string-name><surname>Mayer</surname><given-names>C.</given-names></string-name>, <string-name><surname>Plattner</surname><given-names>C.</given-names></string-name>, <string-name><surname>Laschober</surname><given-names>G.</given-names></string-name>, <string-name><surname>Rieder</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hackl</surname><given-names>H.</given-names></string-name>, <string-name><surname>Krogsdam</surname><given-names>A.</given-names></string-name>, <string-name><surname>Loncova</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Posch</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wilflingseder</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data</article-title>. <source>Genome Med.</source><year>2019</year>; <volume>11</volume>:<fpage>34</fpage>.<pub-id pub-id-type="pmid">31126321</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Traugh</surname><given-names>N.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.S.</given-names></string-name></person-group><article-title>TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells</article-title>. <source>Cancer Res.</source><year>2017</year>; <volume>77</volume>:<fpage>e108</fpage>.<pub-id pub-id-type="pmid">29092952</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiménez-Sánchez</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cast</surname><given-names>O.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>M.L.</given-names></string-name></person-group><article-title>Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods</article-title>. <source>Cancer Res.</source><year>2019</year>; <volume>79</volume>:<fpage>6238</fpage>–<lpage>6246</lpage>.<pub-id pub-id-type="pmid">31641033</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bindea</surname><given-names>G.</given-names></string-name>, <string-name><surname>Mlecnik</surname><given-names>B.</given-names></string-name>, <string-name><surname>Tosolini</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kirilovsky</surname><given-names>A.</given-names></string-name>, <string-name><surname>Waldner</surname><given-names>M.</given-names></string-name>, <string-name><surname>Obenauf</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Angell</surname><given-names>H.</given-names></string-name>, <string-name><surname>Fredriksen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lafontaine</surname><given-names>L.</given-names></string-name>, <string-name><surname>Berger</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</article-title>. <source>Immunity</source>. <year>2013</year>; <volume>39</volume>:<fpage>782</fpage>–<lpage>795</lpage>.<pub-id pub-id-type="pmid">24138885</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davoli</surname><given-names>T.</given-names></string-name>, <string-name><surname>Uno</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wooten</surname><given-names>E.C.</given-names></string-name>, <string-name><surname>Elledge</surname><given-names>S.J.</given-names></string-name></person-group><article-title>Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy</article-title>. <source>Science</source>. <year>2017</year>; <volume>355</volume>:<fpage>eaaf8399</fpage>.<pub-id pub-id-type="pmid">28104840</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Danaher</surname><given-names>P.</given-names></string-name>, <string-name><surname>Warren</surname><given-names>S.</given-names></string-name>, <string-name><surname>Dennis</surname><given-names>L.</given-names></string-name>, <string-name><surname>D’Amico</surname><given-names>L.</given-names></string-name>, <string-name><surname>White</surname><given-names>A.</given-names></string-name>, <string-name><surname>Disis</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Geller</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Odunsi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Beechem</surname><given-names>J.</given-names></string-name>, <string-name><surname>Fling</surname><given-names>S.P.</given-names></string-name></person-group><article-title>Gene expression markers of tumor infiltrating leukocytes</article-title>. <source>J. Immun. Cancer</source>. <year>2017</year>; <volume>5</volume>:<fpage>18</fpage>.</mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Becht</surname><given-names>E.</given-names></string-name>, <string-name><surname>Giraldo</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Lacroix</surname><given-names>L.</given-names></string-name>, <string-name><surname>Buttard</surname><given-names>B.</given-names></string-name>, <string-name><surname>Elarouci</surname><given-names>N.</given-names></string-name>, <string-name><surname>Petitprez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Selves</surname><given-names>J.</given-names></string-name>, <string-name><surname>Laurent-Puig</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sautès-Fridman</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fridman</surname><given-names>W.H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression</article-title>. <source>Genome Biol.</source><year>2016</year>; <volume>17</volume>:<fpage>218</fpage>.<pub-id pub-id-type="pmid">27765066</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aran</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Butte</surname><given-names>A.J.</given-names></string-name></person-group><article-title>xCell: digitally portraying the tissue cellular heterogeneity landscape</article-title>. <source>Genome Biol.</source><year>2017</year>; <volume>18</volume>:<fpage>220</fpage>.<pub-id pub-id-type="pmid">29141660</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miao</surname><given-names>Y.-R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lei</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>G.-Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>A.-Y.</given-names></string-name></person-group><article-title>ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy</article-title>. <source>Adv. Sci.</source><year>2020</year>; <volume>7</volume>:<fpage>1902880</fpage>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gibbs</surname><given-names>D.L.</given-names></string-name></person-group><article-title>Robust classification of Immune Subtypes in Cancer</article-title>. <year>2020</year>; <comment>bioRxiv doi:</comment><comment>18 January 2020, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/2020.01.17.910950</pub-id>.</mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eddy</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Thorsson</surname><given-names>V.</given-names></string-name>, <string-name><surname>Lamb</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>D.L.</given-names></string-name>, <string-name><surname>Heimann</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>J.X.</given-names></string-name>, <string-name><surname>Chung</surname><given-names>V.</given-names></string-name>, <string-name><surname>Chae</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Dang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Vincent</surname><given-names>B.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CRI iAtlas: an interactive portal for immuno-oncology research</article-title>. <source>F1000Research</source>. <year>2020</year>; <volume>9</volume>:<fpage>1082</fpage>.</mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thorsson</surname><given-names>V.</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>D.L.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>S.D.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bortone</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>T.-H.O.</given-names></string-name>, <string-name><surname>Porta-Pardo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>G.F.</given-names></string-name>, <string-name><surname>Plaisier</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Eddy</surname><given-names>J.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The immune landscape of cancer</article-title>. <source>Immunity</source>. <year>2019</year>; <volume>51</volume>:<fpage>411</fpage>–<lpage>412</lpage>.<pub-id pub-id-type="pmid">31433971</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaitsev</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bambouskova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Swain</surname><given-names>A.</given-names></string-name>, <string-name><surname>Artyomov</surname><given-names>M.N.</given-names></string-name></person-group><article-title>Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures</article-title>. <source>Nat. Commun.</source><year>2019</year>; <volume>10</volume>:<fpage>2209</fpage>.<pub-id pub-id-type="pmid">31101809</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
